腹主动脉瘤直径阈值对患者选择与EVAR结局的影响
基于VQI 2003–2017年22,975例择期EVAR,按直径分小、中、大三组。小AAA患者更年轻、合并症少,30天死亡率低;大AAA并发症和死亡风险高。直径与再干预和死亡独立相关。
要点
- 小AAA占择期EVAR的41%,患者更年轻且合并症更少。
- 30天死亡率随直径增大而升高:小0.4%、中0.9%、大1.6%。
- 直径是EVAR后再干预和死亡的独立相关因素。
核心结论
- 小AAA患者选择修复时更年轻且合并症少,EVAR手术和5年死亡风险更低。
- AAA直径与EVAR后再干预和死亡独立相关,可能对结局有重要临床影响。
研究设计与样本
- 回顾性队列研究,纳入Vascular Quality Initiative 2003–2017年无症状AAA择期EVAR共22,975例。
- 按直径分为小(女性<5 cm,男性<5.5 cm)、中(女性5–6.5 cm,男性5.5–6.5 cm)、大(≥6.5 cm)三组。
主要发现
- 小、中、大AAA分别占41%(9353例)、47%(10,842例)、12%(2780例)。
- 30天死亡率:小0.4%、中0.9%、大1.6%(P < .001)。
- 大AAA组心肌梗死(P < .001)、呼吸并发症(P = .001)、肾脏并发症(P < .001)发生率最高。
- 1年无再干预生存:小92%、中89%、大82%(P < .001);5年总生存:小88%、中81%、大75%(P < .001)。
- 与中AAA相比,小AAA的1年再干预或死亡HR 0.82(P = .003)、5年死亡HR 0.78(P = .001);大AAA的1年再干预或死亡HR 1.75(P < .001)、5年死亡HR 1.50(P < .001)。
临床怎么用
- 评估择期EVAR时应考虑AAA直径对术后再干预和死亡风险的独立影响。
- 对小AAA患者,需权衡修复获益与低风险人群中的手术风险。
- 大AAA患者EVAR后并发症和死亡风险较高,应加强围手术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Randomized trials have shown no benefit for repair of small abdominal aortic aneurysms (AAAs), although repair of small AAAs is widely practiced. It has also been suggested that repair of large-diameter AAAs may incur worse outcomes. We sought to examine differences in patient selection, operative outcomes, and survival after elective endovascular aneurysm repair (EVAR) based on AAA diameter thresholds. METHODS: Elective EVARs for asymptomatic AAAs in the Vascular Quality Initiative were studied from 2003 to 2017. AAAs were classified by diameter as small (<5 cm in women, <5.5 cm in men), medium (5-6.5 cm in women, 5.5-6.5 cm in men), and large (≥6.5 cm). Patient characteristics and operative factors were compared using univariate analyses and established risk prediction models. Effects of AAA diameter on reintervention and mortality were assessed using Kaplan-Meier and multivariable Cox regression analyses. RESULTS: Of 22,975 patients undergoing EVAR, 41% (9353), 47% (10,842), and 12% (2780) had small, medium, and large AAAs, respectively. Patients with small AAAs were younger and had fewer comorbidities. Consequently, patients with small AAAs were more likely to have low predicted operative mortality risk and 5-year mortality risk based on risk models (P < .001 for both). For operative outcomes, 30-day mortality was significantly different across diameter categories (small, 0.4%; medium, 0.9%; large, 1.6%; P < .001). EVAR for large AAAs had the highest rates of multiple medical complications, including myocardial infarction (P < .001), respiratory complications (P = .001), and renal complications (P < .001). In contrast, EVAR for small AAAs had the lowest rates of type I endoleak at completion and reoperation during index hospitalization, shortest operative times, and shortest hospital length of stay (P < .001 for all). Aneurysm diameter was associated with differential 1-year reintervention-free survival (92% small vs 89% medium vs 82% large; P < .001) and 5-year overall survival (88% small vs 81% medium vs 75% large; P < .001). Multivariable models showed that compared with medium AAAs, small AAAs had an independent protective effect against 1-year reintervention or death (hazard ratio [HR], 0.82; P = .003) and 5-year mortality (HR, 0.78; P = .001). Conversely, compared with medium AAAs, large AAAs carried an independent increased risk of 1-year reintervention or death (HR, 1.75; P < .001) and 5-year mortality (HR, 1.50; P < .001). CONCLUSIONS: Small AAAs represent >40% of elective EVARs in the Vascular Quality Initiative. Patients with small AAAs selected for repair are younger and have fewer comorbidities. Consequently, EVAR for small AAAs carries lower risk of operative and 5-year mortality. Aneurysm diameter is independently associated with reinterventions and mortality after EVAR, suggesting that AAA diameter may have an important clinical effect on outcomes.
引用
- Jones DW, Deery SE, Schneider DB, et al. Differences in patient selection and outcomes based on abdominal aortic aneurysm diameter thresholds in the Vascular Quality Initiative. J Vasc Surg. 2019. PMID: 31147111. doi:10.1016/j.jvs.2019.02.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。